Screening compound: InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2

Screening compound: InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2
Screening compound: InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M745-0030

Molecular Formula

C22H30N2O3 (C22 H30 N2 O3)

Compound Name

1-cyclopropanecarbonyl-4-{[4-(piperidine-1-carbonyl)phenoxy]methyl}piperidine

IUPAC name

1-cyclopropanecarbonyl-4-{[4-(piperidine-1-carbonyl)phenoxy]methyl}piperidine

SMILES

O=C(C1CC1)N1CCC(COc(cc2)ccc2C(N2CCCCC2)=O)CC1

InChI

InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2

InChI Key

BMTVRCVRSAPVDN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27552908

InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2?
Check Price and Availability of InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C22H30N2O3/c25-21(23-12-2-1-3-13-23)19-6-8-20(9-7-19)27-16-17-10-14-24(15-11-17)22(26)18-4-5-18/h6-9,17-18H,1-5,10-16H2 available by request